Evofem Biosciences, Inc. (EVFM)
OTCMKTS
· Delayed Price · Currency is USD
0.0093
-0.0007 (-7.00%)
Jan 28, 2025, 3:52 PM EST
Evofem Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Net Income | -7.94 | 52.98 | -76.7 | -205.19 | -142.31 | -80.03 | Upgrade
|
| Depreciation & Amortization | 0.35 | 0.48 | 1.02 | 1.02 | 0.3 | 0.26 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.66 | 2.51 | 0.93 | - | - | 0.08 | Upgrade
|
| Stock-Based Compensation | 0.91 | 1.19 | 3.31 | 8.9 | 12.7 | 8.58 | Upgrade
|
| Other Operating Activities | -3.25 | -70.85 | -4.98 | 38.03 | 39.71 | 28.69 | Upgrade
|
| Change in Accounts Receivable | 0.93 | -4.61 | 5.32 | -5.38 | -1.07 | - | Upgrade
|
| Change in Inventory | 0.99 | 2.11 | 1.57 | -0.02 | -6.01 | - | Upgrade
|
| Change in Accounts Payable | 2.66 | 4.09 | 4.47 | -0 | 4.13 | -2.93 | Upgrade
|
| Change in Other Net Operating Assets | 3.04 | 3.14 | -5.35 | 15.99 | -12.28 | -9.74 | Upgrade
|
| Operating Cash Flow | -1.65 | -8.97 | -70.41 | -146.67 | -104.83 | -55.1 | Upgrade
|
| Capital Expenditures | -0.01 | -0 | -0.34 | -2.94 | -2.25 | -0.16 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.03 | Upgrade
|
| Cash Acquisitions | -0.51 | - | - | - | - | - | Upgrade
|
| Divestitures | - | - | - | 0.25 | 0.25 | 0.25 | Upgrade
|
| Investment in Securities | - | - | - | - | 8.23 | -8.23 | Upgrade
|
| Investing Cash Flow | -0.52 | -0 | -0.34 | -2.69 | 6.23 | -8.12 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 50 | - | Upgrade
|
| Long-Term Debt Issued | - | 5.64 | 11.5 | - | - | - | Upgrade
|
| Total Debt Issued | 0.78 | 5.64 | 11.5 | - | 50 | - | Upgrade
|
| Long-Term Debt Repaid | - | -1.15 | -5.89 | - | - | -4.01 | Upgrade
|
| Total Debt Repaid | -0.67 | -1.15 | -5.89 | - | - | -4.01 | Upgrade
|
| Net Debt Issued (Repaid) | 0.11 | 4.49 | 5.61 | - | 50 | -4.01 | Upgrade
|
| Issuance of Common Stock | 0.12 | 0.29 | 57.55 | 81.99 | 107.97 | 84.94 | Upgrade
|
| Repurchase of Common Stock | - | - | -0.02 | -0.33 | -2.87 | -1.57 | Upgrade
|
| Other Financing Activities | 1 | - | -1.2 | -0.97 | -0.87 | -1.29 | Upgrade
|
| Financing Cash Flow | 2.48 | 4.78 | 61.94 | 90.69 | 154.23 | 78.08 | Upgrade
|
| Net Cash Flow | 0.31 | -4.2 | -8.81 | -58.66 | 55.63 | 14.86 | Upgrade
|
| Free Cash Flow | -1.66 | -8.97 | -70.75 | -149.61 | -107.08 | -55.26 | Upgrade
|
| Free Cash Flow Margin | -9.71% | -49.25% | -420.21% | -1814.73% | -24009.64% | - | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.01 | -151.84 | -2142.80 | -2989.73 | -2575.67 | Upgrade
|
| Cash Interest Paid | 0.34 | 0.34 | 0.7 | 1.39 | - | - | Upgrade
|
| Cash Income Tax Paid | 0 | 0 | 0.03 | 0.01 | 0 | 0 | Upgrade
|
| Levered Free Cash Flow | 1.31 | -7.15 | -37.99 | -69.98 | -91.42 | -36.61 | Upgrade
|
| Unlevered Free Cash Flow | 2.95 | -5.51 | -36.68 | -67.02 | -90.12 | -36.61 | Upgrade
|
| Change in Net Working Capital | -8 | -3.98 | -11.91 | -30.25 | 36.1 | 12.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.